altRx vs MedVi: Low Price or Clinical Support?
Quick verdict: altRx vs MedVi — altRx positions itself as the lower-cost, limited-offer option (semaglutide starting at $89/month; tirzepatide $149/month), while MedVi emphasizes a clinically dosed semaglutide program with a promotional first month at $179 and 24/7 certified medical support. This comparison highlights price structure, medication options, clinical support, compounded status, and shipping/availability.
Price and pricing structure compared
Directly on price, altRx is marketed as the most affordable GLP-1 program with a limited-offer starting price: semaglutide from $89/month and tirzepatide from $149/month. altRx notes multi-month discounts in its FAQ (eg, semaglutide drops on 3-, 6-, and 12-month plans). MedVi advertises a winter promotional first month at $179 including free shipping, but its ongoing standalone month can be $299, with a three-month plan at $649 (about $216/month). These differences make cost predictability and long-term price materially different between the two.
Medication options and clinical dosing
altRx offers compounded semaglutide and compounded tirzepatide (GLP-1 + GIP) as part of its program, with clinicians able to prescribe either based on individual health profiles. MedVi offers clinically dosed compounded semaglutide only; it does not offer tirzepatide per the supplied evidence.
Care model and support
Both platforms use a telehealth model with no clinic visits required. altRx provides 100% online medical visits, ongoing care-team support, and claims a responsive care team. MedVi also uses an online intake with clinician review and highlights 24/7 support from certified medical professionals and a personalized physician review that covers a metabolic report and 1:1 guidance.
Compounded medication status and regulatory notes
Neither provider offers FDA-approved branded products in the supplied evidence; both describe their medications as compounded. altRx explicitly notes its medications are compounded and not FDA-approved. MedVi likewise states compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness, or quality. Both platforms say prescriptions are at the discretion of licensed providers and subject to clinician review.
Availability, shipping, and commitments
altRx states membership is available to residents of all 50 U.S. states, though provider availability and prescribing authority vary by state; it also advertises free, discreet 2-day delivery and no membership, insurance, or hidden fees with cancel-anytime terms. MedVi advertises fast, free shipping for the promotional month, no clinic visits, no membership or hidden fees in the supplied materials, and notes that refills are locked in at the ongoing price; MedVi also points out post-promo price increases for ongoing months.
Comparison table: altRx vs MedVi
| Criteria | altRx | MedVi |
|---|---|---|
| Starting price | Semaglutide from $89/mo; Tirzepatide from $149/mo | Promotional first month $179; standalone month $299 |
| Medication options | Compounded semaglutide and compounded tirzepatide | Clinically dosed compounded semaglutide only |
| Care model | 100% online medical visits; ongoing care team support | Simple online intake; 24/7 certified medical support |
| Shipping | Free, discreet 2-day delivery | Fast, free shipping (promo month) |
| Commitment | No membership, cancel anytime; multi-month discounts available | No contract for first month; refills locked in at higher full price |
| Regulatory note | Compounded meds not FDA-approved | Compounded meds not FDA-approved |
Distinctive differences that matter
1) Price guarantee and offers: altRx emphasizes a limited-offer flat low price and multi-month tiers, positioning itself as the most affordable program. MedVi highlights a lower promotional first month but documents a substantial post-promo price increase.
2) Medication breadth: altRx supports both compounded semaglutide and tirzepatide options; MedVi supplies compounded semaglutide only per the evidence provided.
3) Support framing: MedVi promotes 24/7 certified professional support and a physician-reviewed metabolic report; altRx focuses on ongoing care-team support and a quick 2-minute quiz to start.
See altRx pricing and start quiz
Safety and what is not supplied
Both companies state compounded medications are not FDA-approved and that prescribing decisions are made by licensed clinicians; neither provider in the supplied evidence guarantees specific medical outcomes. The evidence does not supply head-to-head clinical outcome data or direct comparisons of efficacy between their compounded products.
Start MedVi promotional month $179
Final thoughts on altRx vs MedVi
When choosing between altRx vs MedVi, your priorities determine the better fit: altRx centers on the lowest advertised starting price and offers both semaglutide and tirzepatide compounded options with 100% online visits. MedVi centers on a clinically dosed semaglutide program with 24/7 certified medical support and a promotional first month at $179 but with higher ongoing rates.
Choose altRx if…
you want the lowest advertised starting price, option for tirzepatide as well as semaglutide, free discreet 2-day delivery, and no membership or long-term commitment as described in the altRx materials.
Choose MedVi if…
you prefer a clinically dosed compounded semaglutide program with 24/7 certified medical support and a promotional first month at $179, accepting that ongoing months may cost more per the supplied evidence.